Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas [Phase 3]
This Phase 3 trial update discusses how the duration of rituximab maintenance therapy may affect outcomes in various non-Hodgkin lymphomas, …
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma [Phase 2]
Phase 2 clinical trial update investigating CD19-targeted CAR T cells for relapsed or refractory large B-cell lymphoma, currently recruiting…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
This clinical trial update notes that a cellular immunotherapy study for relapsed or refractory non-Hodgkin lymphoma is actively recruiting …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Vitamin A and D Supplementation in Allogeneic HCT [Phase 2]
Phase 2 clinical trial in allogeneic hematopoietic cell transplantation is evaluating vitamin A and vitamin D supplementation, currently rec…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study [EARLY_Phase 1]
Feasibility early-phase trial evaluating induction and maintenance therapy with avelumab plus R-CHOP in patients with diffuse large B-cell l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients
A Sohag University clinical trial is investigating whether circulating microRNAs can serve as diagnostic biomarkers for Non-Hodgkin lymphoma…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating UTAA09 injection for recurrent or refractory B-cell non-Hodgkin's lymphoma;…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma [NA]
This document provides an update on a clinical trial evaluating whole-body diffusion-weighted MRI for staging and predicting treatment respo…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update for CMOP±R in untreated Non-Hodgkin lymphoma; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies [Phase 2]
This clinical trial update describes a Phase 2 study of anti-CD19 CAR-T cell therapy for B-cell hematologic malignancies, currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update examines using CD34+ malignant stem cell selection for patients receiving allogeneic stem cell transplants in Pha…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]
This is a Phase II, open-label multicenter study evaluating regimens containing zanubrutinib in newly diagnosed mantle cell lymphoma. The tr…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
This clinical trial update discusses the implications of BCL6 rearrangements across non-Hodgkin lymphomas, including follicular lymphoma, ma…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of TR115 is currently recruiting in patients with relapsed/refractory non-Hodgkin's lymphoma and advanced solid tum…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients [Phase 1]
A Phase I clinical trial update for ETH-155008 (Euthare-155008) in adult patients with non-Hodgkin lymphoma and recurrent acute myeloid leuk…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) [Phase 2]
A Phase 2 clinical trial is evaluating entecavir prophylaxis to prevent hepatitis B reactivation in patients with resolved hepatitis B under…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL) [Phase 1]
This document reports an ongoing Phase 1 study evaluating CLN-978 in adults with relapsed or refractory B-cell non-Hodgkin lymphoma, current…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research [EARLY_Phase 1]
A Phase 1 clinical trial update evaluating the safety and preliminary efficacy of metabolically armed CD19 CAR-T cells (Meta10-19) in relaps…
-
CLINICAL_TRIALS research · 2019-09-10Clinical Trial Update: Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma [Phase 4]
Phase 4 cost-effectiveness study evaluating PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in lymphoma.
-
CLINICAL_TRIALS research · 2019-09-06Clinical Trial Update: Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Clinical trial assessing electrophysiological biomarkers of chemotherapy-related cognitive impairment and recovery; study completed with pos…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL [Phase 1]
Phase I trial evaluating AC0010 in patients with CLL/SLL, mantle cell lymphoma, diffuse large B-cell lymphoma, and other non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial conducted by Sichuan University is evaluating a combination of chidamide with cladribine, gemcitabine, and busulfan…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [NA]
Clinical trial update on caregiver-delivered massage therapy to improve quality of life in pediatric cancer patients; the study (NCT01053494…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma [Phase 1]
Phase 1 clinical trial update on Cytoplasmic Activated PD-1 CAR T Cells for relapsed/refractory B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy [Phase 2]
A Phase II clinical trial update evaluating high-dose therapy in elderly patients with relapsed aggressive non-Hodgkin lymphoma or resistanc…